Clinical Trial Update: Treatment of Hypopigmented Scars With Bimatoprost [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bimatoprost for treating hypopigmented scars; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypopigmentation
• Scars

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Scars, Hypopigmented Scar | Phase 2 | Status: RECRUITING